Kiromic BioPharma Inc. (KRBP)
0.87
-0.13 (-13.00%)
At close: Jan 17, 2025, 3:20 PM
0.00
-100.00%
After-hours Dec 31, 1969, 07:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | 2.80M | 2.07M | 469.80K | 200.00K | 87.50K | 80.90K |
| Gross Profit | -2.80M | -2.07M | -469.80K | -200.00K | -87.50K | -80.90K |
| Operating Income | -19.94M | -31.11M | -25.74M | -19.20M | -3.71M | -3.18M |
| Interest Income | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Income | -20.95M | -34.73M | -25.59M | -19.20M | -3.73M | -3.82M |
| Net Income | -21.29M | -38.18M | -25.65M | -19.20M | -3.75M | -3.82M |
| Selling & General & Admin | 7.52M | 17.19M | 13.94M | 14.14M | 2.50M | 1.76M |
| Research & Development | 9.62M | 13.92M | 11.37M | 5.05M | 1.20M | 1.42M |
| Other Expenses | n/a | n/a | 53.40K | n/a | n/a | n/a |
| Operating Expenses | 17.14M | 31.11M | 25.31M | 19.20M | 3.71M | 3.18M |
| Interest Expense | -1.85M | 166.50K | 12.20K | 3.30K | 22.50K | 633.10K |
| Selling & Marketing Expenses | -2.80M | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 19.94M | 31.11M | 25.31M | 19.20M | 3.71M | 3.18M |
| Income Tax | n/a | 3.45M | 65.60K | 3.30K | 22.50K | -80.24K |
| Shares Outstanding (Basic) | 1.10M | 544.53K | 380.61K | 242.83K | 129.32K | 117.76K |
| Shares Outstanding (Diluted) | 1.10M | 544.53K | 380.61K | 242.83K | 129.32K | 117.76K |
| EPS (Basic) | -21.41 | -70.12 | -67.4 | -79.08 | -29 | -32.4 |
| EPS (Diluted) | -21.41 | -70.12 | -67.4 | -79.08 | -29 | -32.4 |
| EBITDA | -16.30M | -32.50M | -25.74M | -19.00M | -3.62M | -3.10M |
| Depreciation & Amortization | 2.80M | 2.07M | 469.80K | 200.00K | 87.50K | 80.90K |